Skip to main content
Veterinary Medicines

Adrestan 30 mg hard capsules

Authorised
  • Trilostan

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Adrestan 30 mg hard capsules
Adrestan 30 mg harde capsules
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu orali

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    30.00
    milligram(s)
    /
    1.00
    Capsule
Forma farmaċewtika:
  • Kapsula, iebsa
Withdrawal period by route of administration:
  • Oral use
    • Dog
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QH02CA01
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Netherlands
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Tip ta’ proċedura ta’ awtorizzazzjoni:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Dechra Regulatory B.V.
Awtorizzazzjoni għat-tqegħid fis-suq maħruġa:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Genera d.d.
Awtorità responsabbli:
  • Medicines Evaluation Board
Numru tal-awtorizzazzjoni:
  • REG NL 117139
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
  • IE/V/0503/002

Dokumenti

Combined File of all Documents

Published:
Dutch (PDF)
Download

Sommarju tal-karatteristiċi tal-prodott

Published:
English (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."